Samsara Bio Capital, LLC Portfolio Holdings

Samsara Bio Capital, LLC

  • $326 Million
  • Q4 2024

Samsara Bio Capital, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $326 Million distributed in 43 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Scholar Rock Holding Corp with a value of $243M, Arcellx, Inc. with a value of $19.3M, Eliem Therapeutics, Inc. with a value of $10.7M, Rhythm Pharmaceuticals, Inc. with a value of $9.65M, and Nkarta, Inc. with a value of $9.38M.

Examining the 13F form we can see an increase of $154M in the current position value, from $173M to 326M.

Samsara Bio Capital, LLC is based out at Palo Alto, CA

Below you can find more details about Samsara Bio Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $326 Million
Healthcare: $325 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.92B
$243 Million 74.36% of portfolio
5,612,896
Q4 2024 Reduced 17.32%
$2.88B
$19.3 Million 5.92% of portfolio
253,641
Q4 2024 Reduced 28.28%
$109M
$10.7 Million 3.29% of portfolio
2,609,114
Q3 2024 Reduced 20.0%
$2.97B
$9.65 Million 2.96% of portfolio
172,647
Q4 2023 Reduced 50.0%
$80.3M
$9.38 Million 2.88% of portfolio
3,768,035
Q1 2024 Added 31.38%
$129M
$5.91 Million 1.81% of portfolio
2,385,060
Q4 2024 Added 242.6%
$106M
$5.52 Million 1.69% of portfolio
6,130,268
Q3 2023 New
$4.11B
$4.53 Million 1.39% of portfolio
97,625
Q4 2024 Reduced 49.99%
$43.8M
$4.33 Million 1.33% of portfolio
1,562,500
Q3 2023 New
$74.1M
$4.04 Million 1.24% of portfolio
2,196,814
Q2 2024 Added 31.11%
$162M
$1.95 Million 0.6% of portfolio
630,000
Q1 2023 New
$632M
$1.87 Million 0.57% of portfolio
147,319
Q3 2024 Reduced 25.0%
$331M
$1.41 Million 0.43% of portfolio
198,000
Q2 2024 Reduced 50.0%
$212M
$1.18 Million 0.36% of portfolio
405,228
Q4 2024 Reduced 25.0%
$128M
$1.13 Million 0.35% of portfolio
202,348
Q1 2023 New
$59.5M
$815,000 0.25% of portfolio
399,637
Q4 2024 Reduced 50.0%
$1.25B
$603,000 0.18% of portfolio
11,263
Q4 2024 Reduced 50.0%
$5.73M
$412,000 0.13% of portfolio
1,965,689
Q4 2024 Reduced 29.3%
$22M
$208,000 0.06% of portfolio
172,089
Q1 2023 New
$53.9M
$74,000 0.02% of portfolio
78,131
Q1 2023 New
$911M
$34,000 0.01% of portfolio
82,336
Q1 2023 New
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 11.36%
Artiva Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Septerna Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
$0
$1,000 0.0% of portfolio
99,999
Q1 2023 New
Alumis Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Abivax Sa
-
$0 0.0% of portfolio
-
Q4 2023 New
Upstream Bio Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Acelyrin Inc
-
$0 0.0% of portfolio
-
Q4 2023 Added 5.94%
Vtv Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 405.73%
Avadel Pharmaceuticals PLC
-
$0 0.0% of portfolio
-
Q2 2024 New
Cargo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 7.13%
Leap Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 264.91%
Lenz Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 18.33%
Curis Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 12.29%
Neurogene Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 35.44%
Contineum Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced -0.0%
-
$0 0.0% of portfolio
-
Q1 2023 New
Onkure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Palvella Therapeutics Inc Ne
-
$0 0.0% of portfolio
-
Q4 2024 New
Zymeworks Inc
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 31.45%

Summary

  • Portfolio
  • No. of Stocks 43
  • Current Value $326 Million
  • Prior Value $173 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 5 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email